Sotatercept for anemia of myelofibrosis: a phase II investigator-initiated study

Haematologica. 2024 Apr 4. doi: 10.3324/haematol.2023.284078. Online ahead of print.

Authors

Prithviraj Bose¹, Lucia Masarova², Naveen Pemmaraju², Sharon D Bledsoe², Naval G Daver², Elias J Jabbour², Tapan M Kadia², Zeev Estrov², Steven M Kornblau², Michael Andreeff², Nitin Jain², Jorge E Cortes², Gautam Borthakur², Yesid Alvarado², Mary Ann Richie², Mackenzie H Dobbins², Selene A McCrackin², Lingsha Zhou², Sherry A Pierce², Xuemei Wang², Allison M Pike², Guillermo Garcia-Manero², Hagop M Kantarjian², Srdan Verstovsek²

Affiliations

¹ The University of Texas MD Anderson Cancer Center. pbose@mdanderson.org.
² The University of Texas MD Anderson Cancer Center.

PMID: 38572554
DOI: 10.3324/haematol.2023.284078

No abstract available

Grants and funding

P30 CA016672/CA/NCI NIH HHS/United States